PLUS1
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Astrazeneca Plc | LSE:AZN | London | Ordinary Share | GB0009895292 | ORD SHS $0.25 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 29.00 | 0.4% | 7,258.00 | 7,260.00 | 7,263.00 | 7,279.00 | 7,209.00 | 7,260.00 | 2,086,804 | 16:35:17 |
| Industry Sector | Turnover (m) | Profit (m) | EPS - Basic | PE Ratio | Market Cap (m) |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 17,322.1 | 1,562.8 | 133.3 | 56.1 | 95,209 |
Astrazeneca (AZN) News Headlines
Astrazeneca News
| Date | Time | Source | Headline |
|---|---|---|---|
| 05/12/2019 | 08:31 | ALNC |  AstraZeneca, Merck Get Marketing Authorization In China For Lynparza |
| 05/12/2019 | 07:05 | ALNCF | Alliance News Flash Headline |
| 05/12/2019 | 07:01 | UKREG | AstraZeneca PLC Lynparza approved in China for 1L BRCAm ovarian |
| 03/12/2019 | 08:47 | ALNC | AstraZeneca Divests North American Seroquel and Seroquel XR Rights |
| 03/12/2019 | 07:47 | DJN | AstraZeneca Sells Seroquel Rights to Cheplapharm |
| 03/12/2019 | 07:00 | UKREG | AstraZeneca PLC AstraZeneca divests Seroquel rights: US and Canada |
| 02/12/2019 | 15:00 | UKREG | AstraZeneca PLC Block listing Interim Review |
| 29/11/2019 | 08:13 | ALNC | TOP NEWS: AstraZeneca's Imfinzi Gains Priority Review From US FDA |
| 29/11/2019 | 07:43 | DJN | AstraZeneca Gets US License for Imfinzi Lung-Cancer Drug |
| 29/11/2019 | 07:00 | UKREG | AstraZeneca PLC Imfinzi granted FDA Priority Review for SCLC |
1 Year Astrazeneca Chart |
Intraday Astrazeneca Chart |
